NovoCure Stock Still Up Ahead of Cancer Trial Data
NovoCure shares climbed 0.3% Friday, closing the week at $17.96, up 2.2% from last Friday. After the bell, the stock fell to $17.71, with moves more volatile as volume dropped. Small move, but the timing stands out. NovoCure shares are holding around 50% higher than where they closed on April 29, right before the cancer device maker posted Q1 numbers and hiked its 2026 revenue forecast.